Literature DB >> 25650520

Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors.

John Gordon Eley1, Wayne David Newhauser, Daniel Richter, Robert Lüchtenborg, Nami Saito, Christoph Bert.   

Abstract

Beam tracking with scanned carbon ion radiotherapy achieves highly conformal target dose by steering carbon pencil beams to follow moving tumors using real-time magnetic deflection and range modulation. The purpose of this study was to evaluate the robustness of target dose coverage from beam tracking in light of positional uncertainties of moving targets and beams. To accomplish this, we simulated beam tracking for moving targets in both water phantoms and a sample of lung cancer patients using a research treatment planning system. We modeled various deviations from perfect tracking that could arise due to uncertainty in organ motion and limited precision of a scanned ion beam tracking system. We also investigated the effects of interfractional changes in organ motion on target dose coverage by simulating a complete course of treatment using serial (weekly) 4DCTs from six lung cancer patients. For perfect tracking of moving targets, we found that target dose coverage was high ([Formula: see text] was 94.8% for phantoms and 94.3% for lung cancer patients, respectively) but sensitive to changes in the phase of respiration at the start of treatment and to the respiratory period. Phase delays in tracking the moving targets led to large degradation of target dose coverage (up to 22% drop for a 15° delay). Sensitivity to technical uncertainties in beam tracking delivery was minimal for a lung cancer case. However, interfractional changes in anatomy and organ motion led to large decreases in target dose coverage (target coverage dropped approximately 8% due to anatomy and motion changes after 1 week). Our findings provide a better understand of the importance of each of these uncertainties for beam tracking with scanned carbon ion therapy and can be used to inform the design of future scanned ion beam tracking systems.

Entities:  

Mesh:

Year:  2015        PMID: 25650520      PMCID: PMC4384336          DOI: 10.1088/0031-9155/60/4/1717

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  36 in total

1.  Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy.

Authors:  U Weber; G Kraft
Journal:  Phys Med Biol       Date:  1999-11       Impact factor: 3.609

2.  Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions.

Authors:  W Schneider; T Bortfeld; W Schlegel
Journal:  Phys Med Biol       Date:  2000-02       Impact factor: 3.609

3.  4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT.

Authors:  Tinsu Pan; Ting-Yim Lee; Eike Rietzel; George T Y Chen
Journal:  Med Phys       Date:  2004-02       Impact factor: 4.071

Review 4.  Particle radiation therapy using proton and heavier ion beams.

Authors:  Daniela Schulz-Ertner; Hirohiko Tsujii
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

5.  Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties.

Authors:  A J Lomax
Journal:  Phys Med Biol       Date:  2008-01-29       Impact factor: 3.609

6.  Intrafractional motion during proton beam scanning.

Authors:  J Lambert; N Suchowerska; D R McKenzie; M Jackson
Journal:  Phys Med Biol       Date:  2005-10-04       Impact factor: 3.609

7.  Computation of cell survival in heavy ion beams for therapy. The model and its approximation.

Authors:  M Scholz; A M Kellerer; W Kraft-Weyrather; G Kraft
Journal:  Radiat Environ Biophys       Date:  1997-02       Impact factor: 1.925

8.  Geometry of human ribs pertinent to orthopedic chest-wall reconstruction.

Authors:  Marcus Mohr; Eduard Abrams; Christine Engel; William B Long; Michael Bottlang
Journal:  J Biomech       Date:  2006-07-10       Impact factor: 2.712

9.  Results of carbon ion radiotherapy in 152 patients.

Authors:  Daniela Schulz-Ertner; Anna Nikoghosyan; Christoph Thilmann; Thomas Haberer; Oliver Jäkel; Christian Karger; Gerhard Kraft; Michael Wannenmacher; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

10.  Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.

Authors:  Stephanie E Combs; Daniel Habermehl; Meinhard Kieser; Constantin Dreher; Jens Werner; Renate Haselmann; Oliver Jäkel; Dirk Jäger; Markus W Büchler; Jürgen Debus
Journal:  BMC Cancer       Date:  2013-09-14       Impact factor: 4.430

View more
  9 in total

1.  Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.

Authors:  Jie Shan; Yu An; Martin Bues; Steven E Schild; Wei Liu
Journal:  Med Phys       Date:  2017-12-05       Impact factor: 4.071

2.  Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Authors:  Wei Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Yu-Hui Chang; Zhifei Wen; Jiajian Shen; Joshua B Stoker; Xiaoning Ding; Yanle Hu; Narayan Sahoo; Michael G Herman; Carlos Vargas; Sameer Keole; William Wong; Martin Bues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-10       Impact factor: 7.038

3.  Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report.

Authors:  Ruifeng Liu; Hongtao Luo; Qiuning Zhang; Shilong Sun; Zhiqiang Liu; Xiaohu Wang; Yichao Geng; Xueshan Zhao
Journal:  Mol Clin Oncol       Date:  2022-05-19

4.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

Review 5.  Particle therapy of moving targets-the strategies for tumour motion monitoring and moving targets irradiation.

Authors:  Tomasz Kubiak
Journal:  Br J Radiol       Date:  2016-07-19       Impact factor: 3.039

6.  Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Authors:  Bouthaina Shbib Dabaja; Bradford S Hoppe; John P Plastaras; Wayne Newhauser; Katerina Rosolova; Stella Flampouri; Radhe Mohan; N George Mikhaeel; Youlia Kirova; Lena Specht; Joachim Yahalom
Journal:  Blood       Date:  2018-08-14       Impact factor: 22.113

7.  Proton Therapy For Lymphomas: Current State Of The Art.

Authors:  Umberto Ricardi; Maja V Maraldo; Mario Levis; Rahul R Parikh
Journal:  Onco Targets Ther       Date:  2019-10-01       Impact factor: 4.147

8.  Dosimetric Validation of a System to Treat Moving Tumors Using Scanned Ion Beams That Are Synchronized With Anatomical Motion.

Authors:  Michelle Lis; Wayne Newhauser; Marco Donetti; Moritz Wolf; Timo Steinsberger; Athena Paz; Christian Graeff
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

Review 9.  Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.

Authors:  Julia M Pakela; Antje Knopf; Lei Dong; Antoni Rucinski; Wei Zou
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.